- Open Access
Haplotype of gene Nedd4 binding protein 2 associated with sporadic nasopharyngeal carcinoma in the Southern Chinese population
© Zheng et al; licensee BioMed Central Ltd. 2007
- Received: 06 May 2007
- Accepted: 13 July 2007
- Published: 13 July 2007
Bcl-3 as an oncoprotein is overexpressed in nasopharyngeal carcinoma (NPC). Nedd4 binding protein 2 (N4BP2), which is located in the NPC susceptibility locus, is a Bcl-3 binding protein. This study is aimed to explore the association between N4BP2 genetic polymorphism and the risk of NPC.
We performed a hospital-based case-control study, including 531 sporadic NPC and 480 cancer-free control subjects from southern China. PCR-sequencing was carried out on Exons, promoter region and nearby introns of the N4BP2 gene. The expression pattern of N4BP2 and Bcl-3 was also analyzed.
We observed a statistically significant difference in haplotype blocks ATTA and GTTG between cases and controls. In addition, three novel SNPs were identified, two of which were in exons (loc123-e3l-snp2, position 39868005, A/G, Met171Val; RS17511668-SNP2, position 39926432, G/A, Glu118Lys), and one was in the intron6 (RS794001-SNP1, position 39944127, T/G). Moreover, N4BP2 was at higher levels in a majority of tumor tissues examined, relative to paired normal tissues.
These data suggest that haplotype blocks ATTA and GTTG of N4BP2 is correlation with the risk of sporadic nasopharyngeal carcinoma in the Southern Chinese population and N4BP2 has a potential role in the development of NPC.
- Mismatch Repair Gene
- Nasopharyngeal Tissue
- Southern Chinese Population
- Haplotype Association Test
- Nasopharyngeal Epithelial Cell Line
Bcl-3 was originally identified as expressed in chronic B cell lymphocytic leukemia . Many cell growth and survival promoters can induce Bcl-3 expression, and Bcl-3 overexpression has been detected in other cancers such as nasopharyngeal carcinoma (NPC) [2, 3]. Nedd4 binding protein 2 (N4BP2, GenBank:AY267013) is a Bcl-3 binding protein, N4BP2 protein contains a polynucleotide kinase domain (PNK) at the N-terminus and a Small MutS Related (Smr) domain with nicking endonuclease activity near C-terminus . MutS is central to the DNA mismatch repair (MMR) systems that are responsible for maintaining genome stability and protecting against mutation, Mutations in these genes are linked to the development of certain types of cancer [4, 5]. Since N4BP2 contains a MutS-related domain, N4BP2 may play a role in MMR.
NPC is an epithelial tumor with an exceptionally high incidence in southern China, particularly in the Guangdong province [6, 7]. Etiological and epidemiological studies have suggested that susceptibility genes may determine the predisposition to developing NPC [8, 9]. Previously, we reported the use of 382 polymorphic microsatellite markers to identify a candidate susceptibility locus that mapped to chromosome 4p15.1-q12 (D4S2950-D4S2916) in a subset of NPC families . Further analysis identified SNPs within or near this region, strongly suggesting the presence of an NPC susceptibility locus adjacent to the LOC344967 , very close to the N4BP2 gene.
We thus hypothesized that SNPs or other variation in the N4BP2 gene lead to a predisposition to developing NPC. We further hypothesized that the N4BP2 gene plays a role in tumorigenesis. To address these hypotheses, we examined N4BP2 haplotypes among NPC patients from southern China. We also examined mRNA levels of Bcl-3 and N4BP2 in NPC cell lines and tissues.
Profile of the study subjects
Control (n = 480)
Case (n = 531)
37 ± 10
40 ± 10
Genomic DNA was extracted from 5–10 ml peripheral blood using the QIAamp DNA Blood Midi kit (Qiagen, German).
Primers used for SNPs
Product size (bp)
Long-distance PCR was performed in a total volume of 15 μl containing 200 ng of genomic DNA, 1.5 μl 10× Buffer, 50 μM dNTPs, 0.3 μM each primer, and 1U Taq DNA polymerase. Samples were amplified with each pair of primers described above as follows: 94°C for 3 min, 10 cycles of 94°C for 30 s, 63°C for 1 min, and 72°C for 1 min; 25 cycles of 94°C for 30 s, 58°C for 1 min, 72°C for 1 min, and a final extension at 72°C for 7 min. First-round PCR products were diluted 5-fold for the second-round of PCR. Round 2 PCR conditions were 94°C for 3 min, 10 cycles at 94°C for 30 s, 65°C for 1 min, and 72°C for 1 min; 30 cycles at 94°C for 30 s, 62°C for 1 min, and 72°C for 1 min, and 72°C for 7 min. PCR products were visualized on a 1.2% agarose gel, stained with ethidium bromide, and visualized by a transilluminator.
PCR products were sequence using ABI377 or ABI3730 sequencers (PE Applied biosystem). Base calling, contig assembly contigs, and mutation detection was performed using Polyphred package (Polyphred, Phred/Phrap/Consed) . All traces were visually inspected by at least two observers.
Unrelated control samples were selected for analysis using the Hardy-Weinberg Equilibrium (HWE) test using an exact test. Standard EM algorithm was used to infer haplotype and estimate population frequency. Single marker and haplotype association test and significance estimation were performed using a permutation test.
Cell Culture and Treatment
NP69 (an SV40 large T antigen-immortalized nasopharyngeal epithelial cell line) and NP69-LMP1 (NP69 cells transfected with the LMP1 gene) were cultured in Keratinocyte-SFM medium (GibcoBRL) with Bovine Pituitary Extract and rEGF. C666-1 (a poorly differentiated nasopharyngeal epithelial cell line carrying the Epstein-Barr virus) was grown in RPMI 1640 supplemented with 10% fetal bovine serum (FBS, Hyclone, Utah, USA). CNE-1 (a highly-differentiated nasopharyngeal epithelial cell line), CNE-2 (a poorly differentiated nasopharyngeal epithelial cell line) and Sune(a poorly differentiated nasopharyngeal epithelial cell line carried Epstein-Barr virus) were maintained in RPMI 1640 with 10% FBS.
Tissue collection and RT-PCR
A total of 21 tissues were collected from Sun Yat-sen University Cancer Center. Six paired matched tissues from different organs included esophagus, stomach, liver, lung, cervix and breast; nine nasopharyngeal tissues contained 2 chronic nasopharynx inflammation (Inf.), 1 Differentiated Carcinoma (DNK), 4 Undifferentiated Carcinoma (NDNK), 1 low differentiated squamous carcinoma (LDS) and 1 non-Hodgkin's lymphoma (NHL). RNA was extracted using TRIZOL Reagent (Invitrogen, Carlsbad, CA), and reverse transcription was performed using the TaKaRa RNA PCR kit (AMV) Ver.3.0 (TaKaRa BIO, Shiga, Japan). PCR to detect N4BP2 was performed using the following primers (N4BP2-L: 5'-AAAGGGAGACCCTTATGTTTGA-3'; N4BP2-R: 5'-AAATCAAACCTCACTTGCATTT-3') and Bcl-3 with primers (Bcl-3-L:5'-tcctctggtgaacctgccta-3'; Bcl-3-R:5'-gaagaccattggagctgagg-3') and β-actin as control with primers (5'-acactgtgcccatctacgagggg-3' and 5'-atgatggagttgaaggtagtttcgtggat-3').
Amino acid change
SNP allele frequency comparison between cases and controls
Case, Control Ratiosa
Case, Control Ratiosb
Block 2: ATTA
Block 2: GTTG
Block 1: CAA
Block 1: GAG
Block 2: AGTA
Block 1: CGG
Block 2: GTCG
Block 1: CAG
Block 2: GTTA
Block 2: GTCA
10000 permutations performed.
N4BP2 and Bcl-3 expressed in cells and tissues
We previously showed, by linkage analysis that an NPC susceptibility locus maps to chromosome 4 near the LOC344967. Here, we extend this analysis in an effort to identify a bona fide NPC susceptibility gene. N4BP2 is a candidate gene in this region, and we thus sought to examine the correlation between genetic polymorphisms in N4BP2, a mismatch repair gene, and the incidence of NPC. SNPs have been shown to be extremely useful for studying the association between genomic regions and disease . Several studies have demonstrated that polymorphic variation in mismatch repair genes contributes to susceptibility to certain cancers [15, 16]. In addition, several pieces of evidence suggest that nasopharyngeal carcinogenesis is associated with individual susceptibility caused by SNPs. Our results show that, although there is no significant difference in SNPs between cases and controls, there are two haplotypes, ATTA and GTTG, the distribution of which differed between case and control groups. Just as the report that almost not any difference in the allele frequencies of five SNPs within the TNFSF4 gene individuals suffered from coronary artery disease versus the controls while there were significantly more frequent of the possible haplotypes from this five TNFSF4 SNPs in individuals with coronary artery disease than controls . Insight into this paradox has been provided in a recent review by Schaid . Haplotypes, the grouping of closely linked alleles on a chromosome, make an important contribution to the study of the genetic basis of disease. Schaid  explained that for case-control studies, methodological approach based on haplotype has more advantage than single-locus analysis as the SNPs are in LD with a causative diallelic locus; in particular, haplotype-based methods have greater power when the marker alleles are in strong LD with causative alleles. Haplotype methods are more useful for variants which are more recently evolved, rarer and more causative than for variants which are older and more common. This may help explain why the haplotypes ATTA and GTTG exhibit differences in frequency between case and control groups while individual SNPs do not.
N4BP2 is a Bcl-3 binding protein, and Bcl-3 is an oncoprotein that is overexpressed in certain cancers, including NPC. Our analysis of N4BP2 and Bcl-3 expression levels suggest that expression of these genes is correlated, suggesting they may be co-regulated. We also found that N4BP2 and Bcl-3 are expressed in all NPC cell lines examined and were higher for certain cancers. These observations are consistent with previous reports.
Above all, we found that two N4BP2 haplotypes, ATTA and GTTG, are correlated with NPC. This will be useful for predict the development of NPC. In addition, N4BP2 and Bcl-3 mRNA levels were elevated in tumors, including NPC tumors, which suggest new therapeutic targets for fighting NPC.
This work was supported by grants from the Natural Science Foundation of Guangdong Province, China (No. A1080202), the National High Technology Research and Development Program of China (863 Program) (No. 2001AA221171) and the Major State Basic Research Development Program of China (973 Program) (No. G1998051201).
- McKeithan T, Ohno H, Rowley J, Diaz M: Cloning of the breakpoint junction of the translocation 14;19 in chronic lymphocytic leukemia. Haematol Blood Transfus. 1989, 32: 335-336.PubMedGoogle Scholar
- Thornburg NJ, Pathmanathan R, Raab-Traub N: Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 2003, 63: 8293-8301.PubMedGoogle Scholar
- Watanabe N, Wachi S, Fujita T: Identification and characterization of BCL-3-binding protein: implications for transcription and DNA repair or recombination. J Biol Chem. 2003, 278: 26102-26110. 10.1074/jbc.M303518200.View ArticlePubMedGoogle Scholar
- Lamers MH, Perrakis A, Enzlin JH, Winterwerp HH, de Wind N, Sixma TK: The crystal structure of DNA mismatch repair protein MutS binding to a G × T mismatch. Nature. 2000, 407: 711-717. 10.1038/35037523.View ArticlePubMedGoogle Scholar
- Obmolova G, Ban C, Hsieh P, Yang W: Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature. 2000, 407: 703-710. 10.1038/35037509.View ArticlePubMedGoogle Scholar
- Chen DL, Huang TB: A case-control study of risk factors of nasopharyngeal carcinoma. Cancer Lett. 1997, 117: 17-22. 10.1016/S0304-3835(97)00182-1.View ArticlePubMedGoogle Scholar
- Hsu JL, Glaser SL: Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol. 2000, 34: 27-53. 10.1016/S1040-8428(00)00046-9.View ArticlePubMedGoogle Scholar
- Hildesheim A, Dosemeci M, Chan CC, Chen CJ, Cheng YJ, Hsu MM, Chen IH, Mittl BF, Sun B, Levine PH, Chen JY, Brinton LA, Yang CS: Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2001, 10: 1145-1153.PubMedGoogle Scholar
- Cheng YJ, Hildesheim A, Hsu MM, Chen IH, Brinton LA, Levine PH, Chen CJ, Yang CS: Cigarette smoking, alcohol consumption and risk of nasopharyngeal carcinoma in Taiwan. Cancer Causes Control. 1999, 10: 201-207. 10.1023/A:1008893109257.View ArticlePubMedGoogle Scholar
- Feng BJ, Huang W, Shugart YY, Lee MK, Zhang F, Xia JC, Wang HY, Huang TB, Jian SW, Huang P, Feng QS, Huang LX, Yu XJ, Li D, Chen LZ, Jia WH, Fang Y, Huang HM, Zhu JL, Liu XM, Zhao Y, Liu WQ, Deng MQ, Hu WH, Wu SX, Mo HY, Hong MF, King MC, Chen Z, Zeng YX: Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet. 2002, 31: 395-399.PubMedGoogle Scholar
- Jiang RC, Qin HD, Zeng MS, Huang W, Feng BJ, Zhang F, Chen HK, Jia WH, Chen LZ, Feng QS, Zhang RH, Yu XJ, Zheng MZ, Zeng YX: A functional variant in the transcriptional regulatory region of gene LOC344967 cosegregates with disease phenotype in familial nasopharyngeal carcinoma. Cancer Res. 2006, 66: 693-700. 10.1158/0008-5472.CAN-05-2166.View ArticlePubMedGoogle Scholar
- Primer3. [http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi]
- Department of genome sciences university of Washington. [http://droog.gs.washington.edu/]
- Kwok PY, Gu Z: Single nucleotide polymorphism libraries: why and how are we building them?. Mol Med Today. 1999, 5: 538-543. 10.1016/S1357-4310(99)01601-9.View ArticlePubMedGoogle Scholar
- Kawakami T, Shiina H, Igawa M, Deguchi M, Nakajima K, Ogishima T, Tokizane T, Urakami S, Enokida H, Miura K, Ishii N, Kane CJ, Carroll PR, Dahiya R: Inactivation of the hMSH3 mismatch repair gene in bladder cancer. Biochem Biophys Res Commun. 2004, 325: 934-942. 10.1016/j.bbrc.2004.10.114.View ArticlePubMedGoogle Scholar
- Apessos A, Mihalatos M, Danielidis I, Kallimanis G, Agnantis NJ, Triantafillidis JK, Fountzilas G, Kosmidis PA, Razis E, Georgoulias VA, Nasioulas G: hMSH2 is the most commonly mutated MMR gene in a cohort of Greek HNPCC patients. Br J Cancer. 2005, 92: 396-404.PubMed CentralPubMedGoogle Scholar
- Wang X, Ria M, Kelmenson PM, Eriksson P, Higgins DC, Samnegård A, Petros C, Rollins J, Bennet AM, Wiman B, de Faire U, Wennberg C, Olsson PG, Ishii N, Sugamura K, Hamsten A, Forsman-Semb K, Lagercrantz J, Paigen B: Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nat Genet. 2005, 37: 365-372. 10.1038/ng1524.View ArticlePubMedGoogle Scholar
- Schaid DJ: Evaluating associations of haplotypes with traits. Genet Epidemiol. 2004, 27: 348-364. 10.1002/gepi.20037.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.